SYnAbs
SYnAbs develops custom monoclonal antibodies targeting haptens, GPCRs, transmembrane proteins, and difficult antigens for therapeutic and research applications.
SYnAbs specializes in generating highly specific monoclonal antibodies against small molecules, membrane receptors, and transmembrane proteins. The company offers custom antibody development services and produces primary and secondary monoclonal antibodies for various applications including infectious diseases, epigenetic modifications, and cytokine research.